drugset / Trial / NCT03818295
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers
NaSingle-groupOpen-labelOther
Summary
The primary objective is to characterize the pharmacokinetics (PK) of praliciguat and total radioactivity and to assess the elimination of total radioactivity from a single oral dose of \[14C\]-praliciguat.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2019-04-24
- Completion
- 2019-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Praliciguat | Small molecule | 10 mg | Oral |
Indications
No indication recorded.